Skip to main content

Readers' Picks:'s Top 10

Cramer takes a look at Sirius, and Michael Latwis reports on Pfizer.

In case you missed them, here are the 10 most popular videos and articles on for the past three days (as of Dec. 6). Cramer takes a look at Sirius, and Michael Latwis reports on Pfizer.


Merger Watch for Sirius by Jim Cramer, published Dec. 5 at 8:58 a.m. EST.

Softening sales may make a linkup its salvation.


Karmazin Strikes Back by Scott Moritz, published Dec. 6 at 2:01 p.m. EST.

'I don't see it as a slowdown,' he says of Sirius' retail travails.


Finisar Flop Hits JDSU by Scott Moritz, published Dec. 1 at 11:59 a.m. EST.

A revenue shortfall trims Avanex and Bookham too.


Dow 16,000 in '07 by James Altucher, published Dec. 7 at 10:38 a.m. EST.

This bull won't tire till long-ignored names like Microsoft and GE break out.


Cramer Video: Tech Alive by Jim Cramer, published Dec. 6 at 11:37 a.m. EST.

Jim talks chips, the housing market, and struggles over drugs and oil.

Scroll to Continue

TheStreet Recommends


iPhone Rumor Gnaws at Apple by Katie Dean, published Dec. 7 at 1:20 p.m. EST.

Shares lose some steam on talk of a product delay.


Glut Fears Crack Corning by Scott Moritz, published Dec. 7 at 12:06 p.m. EST.

Shares slump 4% after a big LCD customer cools expectations.


Pfizer's Worst-Case Scenario by Michael Latwis, published Dec. 5 at 7:50 a.m. EST.

The latest surprising setback may lead to some strategic reverberations.


Leaving Qualcomm Alone by Cody Willard, published Dec. 6 at 7:42 a.m. EST.

It's no short, but not worth owning, either.



Sirius Blinks in the Satellite-Radio Wars by Joan Lappin, published Dec. 5 at 3:43 p.m. EST.

But despite the short-term setback, the future is rosy.

David Morrow is editor-in-chief of In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.